SEARCH

SEARCH BY CITATION

References

  • Aicher S. A., Springston M., Berger S. B., Reis D. J., Wahlestedt C. (1991) Receptor-selective analogs demonstrate NPY/PYY receptor heterogeneity in rat brain. Neurosci. Lett. 130, 3236.
  • Ambrósio A. F., Silva A. P., Malva J. O., Mesquita J. F., Carvalho A. P., Carvalho C. M. (2000) Role of desensitization of AMPA receptors on the neuronal viability and on the [Ca2+]i changes in cultured rat hippocampal neurons. Eur. J. Neurosci. 12, 20212031.
  • Attwell D., Barbour B., Szatkowski M. (1993) Non-vesicular release of neurotransmitters. Neuron 11, 401407.
  • Balasubramaniam A. (1997) Neuropeptide Y family of hormones: Receptor Subtypes and antagonists. Peptides 18, 445457.
  • Baraban S. C., Hollopeter G., Erickson J. C., Schwartzkroin P. A., Palmiter R. D. (1997) Knock-out mice reveal a critical antiepileptic role for neuropeptide Y. J. Neurosci. 17, 89278936.
  • Bijak M. (1999) Neuropeptide Y suppresses epileptiform activity in rat frontal cortex and hippocampus in vitro via different NPY receptor subtypes. Neurosci. Lett. 268, 115118.
  • Brewer G. J., Torricelli J. R., Evege E. K., Price P. J. (1993) Optimized survival of hippocampal neurons in B27-supplemented neurobasalTM, a new serum-free medium combination. J. Neurosci. Res. 35, 567576.
  • Brooks P. A., Kelly J. S., Allen J. M., Smith D. A. S., Stone T. W. (1987) Direct excitatory effects of neuropeptide Y (NPY) in rat hippocampal neurones in vitro. Brain Res. 408, 295298.
  • Colmers W. F., Klapstein G. J., Fournier A., St-Pierre S., Treherne K. A. (1991) Pre-synaptic inhibition by neuropeptide Y in rat hippocampal slice in vitro is mediated by a Y2 receptor. Br. J. Pharmacol. 102, 4144.
  • Doods H. N., Wieland H. A., Engel W., Eberlein W., Willim K., Entzeroth M., Wienen W., Rudolf K. (1996) BIBP 3226, the first selective neuropeptide Y1 receptor antagonist: a review of its pharmacological properties. Regul. Peptides 65, 7177.
  • Doods H., Gaida W., Wieland H. A., Dollinger H., Schnorrenberg G., Esser F., Engel W., Eberlein W., Rudolf K. (1999) BIIB0246: a selective and high affinity neuropeptide Y Y2 receptor antagonist. Eur. J. Pharmacol. 384, R3R5.
  • Dumont Y., Fournier A., St-Pierre S., Quirion R. (1993) Comparative characterization and autoradiographic distribution of neuropeptide Y receptor subtypes in the rat brain. J. Neurosci. 13, 7386.
  • Dumont Y., St-Pierre J. A., Quirion R. (1996) Comparative autoradiographic distribution of neuropeptide Y Y1 receptors visualized with the Y1 receptor agonist [125I][Leu31, Pro34]PYY and the non-peptide antagonist [3H]BIBP3226. Neuroreport 7, 901904.
  • Dumont Y., Fournier A., Quirion R. (1998) Expression and characterization of the neuropeptide Y Y5 receptor subtype in the rat brain. J. Neurosci. 18, 55655574.
  • Dunkley P. R., Heath J. W., Harrison S. M., Jarvie P. E., Glenfield P. J., Rostas J. A. (1988) A rapid Percoll gradient procedure for isolation of synaptosomes directly from an S1 fraction: homogeneity and morphology of subcellular fractions. Brain Res. 441, 5971.
  • Ellis Y. & Davies J. A. (1994) The effect of neuropeptides on the release of neurotransmitter amino acids from rat striatum. Neuropeptides 26, 6569.
  • Greber S., Schwarzer C., Sperk G. (1994) Neuropeptide Y inhibits potassium-stimulated glutamate release through Y2 receptors in rat hippomcampal slices in vitro. Br. J. Pharmacol. 113, 737740.
  • Grouzmann E., Buclin T., Martire M., Cannizzaro C., Dörner B., Razaname A., Mutter M. (1997) Characterization of a selective antagonist of neuropeptide Y at the Y2 receptor. J. Biol. Chem. 272, 76997706.
  • Grynkiewicz M. E., Poenie M., Tsien R. Y. (1985) A new generation of Ca2+ indicators with greatly improved fluorescent properties. J. Biol. Chem. 260, 34403450.
  • Ho M. W. Y., Beck-Sickinger A. G., Colmers W. F. (2000) Neuropeptide Y5 receptors reduce synaptic excitation in proximal subiculum, but not epileptiform activity in rat hippocampal slices. J. Neurophysiol. 83, 723734.
  • King P. J., Widdowson P. S., Doods H. N., Williams G. (1999) Regulation of neuropeptide Y release by neuropeptide Y receptor ligands and calcium channel antagonists in hypothalamic slices. J. Neurochem. 73, 641645.
  • Klapstein G. J. & Colmers W. F. (1992) 4-Aminopyridine and low Ca2+ differentiate pre-synaptic inhibition mediated by neuropeptide Y, baclofen and 2-chloroadenosine in rat hippocampal CA1 in vitro. Br. J. Pharmacol. 105, 470474.
  • Klapstein G. J. & Colmers W. F. (1997) Neuropeptide Y suppresses epileptiform activity in rat hippocampus in vitro. J. Neurophysiol. 78, 16511661.
  • Larsen P. J., Sheikh S. P., Jakobsen C. R., Scwartz T. W., Mikkelsen J. D. (1993) Regional distribution of putative NPY Y1 receptors and neurons expressing Y1 mRNA in forebrain areas of the rat central nervous system. Eur. J. Neurosci. 5, 16221637.
  • Lee C. C. & Miller R. J. (1998) Is there really an NPY Y3 receptor? Regul. Peptides 75–76, 7178.
  • Lundberg J. M., Modin A., Malmström R. E. (1996) Recent developments with neuropeptide Y receptor antagonists. Trends Pharmacol. Sci. 17, 301304.
  • McCullough L. A., Egan T. M., Westfall T. C. (1998) Neuropeptide Y receptors involved in calcium channel regulation in PC12 cells. Regul. Peptides 75–76, 101107.
  • McMahon T. H., Foran P., Dolly J. O., Verhage M., Wiegant V. M., Nicholls D. G. (1992) Tetanus toxin and botulinum toxins type A and B inhibit glutamate, γ-aminobutyric acid, aspartate, and met-enkephalin release from synaptosomes. J. Biol. Chem. 267, 2133821343.
  • McQuiston A. R. & Colmers W. F. (1996) Neuropeptide Y2 receptors inhibit the frequency of spontaneous but not miniature EPSCs in CA3 pyramidal cells of rat hippocampus. J. Neurophysiol. 76, 31593168.
  • Malva J. O., Carvalho A. P., Carvalho C. M. (1996) Domoic acid induces the release of glutamate in the rat hippocampal CA3 sub-region. Neuroreport 7, 13301344.
  • Marsh D. J., Baraban S. C., Hollopeter G., Palmiter R. D. (1999) Role of the Y5 neuropeptide Y receptor in limbic seizures. Proc. Natl Acad. Sci. USA 96, 1351813523.
  • Michel M. C., Beck-Sickinger A., Cox H., Doods H. N., Herzog H., Larhammar D., Quirion R., Schwartz T., Westfall T. (1998) XVI. International union of pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharmacol. Rev. 50, 143150.
  • Nicholls D. G. (1993) The glutamatergic nerve terminal. Eur. J. Biochem. 212, 613631.
  • Nicholls D. G., Sihra T. S., Sanchez-Prieto J. (1987) Calcium-dependent and independent release of glutamate from synaptosomes monitored by continuous fluorometry. J. Neurochem. 49, 5057.
  • Parker R. M. C. & Herzog H. (1999) Regional distribution of Y-receptor subtype mRNA in rat brain. Eur. J. Neurosci. 11, 14311448.
  • Patrylo P. R., Van Den Pol A. N., Spencer D. D., Williamson A. (1999) NPY inhibits glutamatergic excitation in the epileptic human dentate gyrus. J. Neurophysiol. 82, 478483.
  • Rhim H., Kinney G. A., Emmerson P. J., Miller R. J. (1997) Regulation of neurotransmission in the arcuate nucleus of the rat by different neuropeptide Y receptors. J. Neurosci. 17, 29802989.
  • Rimland J. M., Seward E. P., Humbert Y., Ratti E., Trist D. G., North R. A. (1996) Coexpression with potassium channel subunits used to clone the Y2 receptor for neuropeptide Y. Mol. Pharmacol. 49, 387390.
  • Rose P. M., Fernandes P., Lynch J. S., Frazier S. T., Fisher S. M., Kodukula K., Kienzle B., Seethala R. (1995) Cloning and functional expression of a cDNA encoding a human type 2 neuropeptide Y receptor. J. Biol. Chem. 270, 2266122664.
  • Silva A. P., Malva J. O., Carvalho A. P., Carvalho C. M. (2000) Modulation of glutamate release and calcium influx by NPY Y1 and Y2 receptors in the rat hippocampus. Eur. J. Neurosci. 12, 46p.
  • Statnick M. A., Douglas A. S., Gackenheimer S., Johnson D., Beavers L., Mayne N. G., Burnett J. P., Gadski R., Gehlert D. R. (1998) Characterization of the neuropeptide Y5 receptor in the human hypothalamus: a lack of correlation between Y5 mRNA levels and binding sites. Brain Res. 810, 1626.
  • St-Pierre J., Dumont Y., Nouel D., Herzog H., Hamel E., Quirion R. (1998) Preferential expression of the neuropeptide Y1 over the Y2 receptor subtype in cultured hippocampal neurones and cloning of the rat Y2 receptor. Br. J. Pharmacol. 123, 183194.
  • St-Pierre J., Nouel D., Dumont Y., Beaudet A., Quirion R. (2000) Association of neuropeptide Y Y1 receptors with glutamate-positive and NPY-positive neurons in rat hippocampal cultures. Eur. J. Neurosci. 12, 13191330.
  • Toth P. T., Bindokas V. P., Bleakman D., Colmers W. F., Miller R. J. (1993) Mechanism of pre-synaptic inhibition by neuropeptide Y at sympathetic nerve terminals. Nature 364, 635639.
  • Wahlestedt C., Pich E. M., Koob G. F., Yee F., Heilig M. (1993) Modulation of anxiety and neuropeptide Y-Y1 receptors by antisense oligodeoxynucleotides. Science 259, 528531.
  • Wan C. P. & Benjamin H. S. (1995) Neuropeptide Y receptor subtypes. Lif. Sci. 56, 10551064.
  • Weiser T., Wieland H. A., Doods H. N. (2000) Effects of the neuropeptide Y Y2 receptor antagonist BIIE0246 on pre-synaptic inhibition by neuropeptide Y in rat hippocampal slices. Eur. J. Pharmacol. 404, 133136.
  • Whittaker E., Vereker E., Lynch M. A. (1999) Neuropeptide Y inhibits glutamate release and long-term potentiation in rat dentate gyrus. Brain Res. 827, 229233.
  • Wieland H. A., Willim K. D., Entzeroth M., Wienen W., Rudolf K., Eberlein W., Engel W., Doods H. N. (1995) Subtype selectivity and antagonistic profile of the non-peptide Y1 receptor antagonist BIBP 3226. J. Pharmacol. Exp. Ther. 275, 143149.
  • Wieland H. A., Engel W., Eberlein W., Rudolf K., Doods H. N. (1998) Subtype selectivity of the novel non-peptide neuropeptide Y Y1 receptor antagonist BIBO 3304 and its effect on feeding in rodents. Br. J. Pharmacol. 125, 549555.
  • Woldbye D. P. D., Larsen P. J., Mikkelsen J. D., Klemp K., Madsen T. M., Bolwig T. G. (1997) Powerful inhibition of kainic acid seizures by neuropeptide Y via Y5-like receptors. Nature Med. 3, 761764.